NEW YORK (GenomeWeb) — NanoView Biosciences said today that it has closed a $10 million Series B round of financing.

The round was led by Northpond Ventures and included existing investors Sands Capital Ventures and PBM Capital Group.

Boston-based NanoView said it will use the funding to complete development of its ExoView system for the characterization of exosomes and other extracellular vesicles, as well as prepare for the product's commercial launch in early 2019.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

 Senator Lamar Alexander (R-Tenn.), who chairs the Senate health committee, will be retiring at the end of his term, Stat News reports.

The Wall Street Journal reports on the US Centers for Disease Control and Prevention's use of genetic approaches to study foodborne illnesses.

UCSF researchers find that having two X chromosomes may contribute to women's longer lifespans, according to Discover's D-brief blog.

In PNAS this week: immune cell profiling of wild baboons by social status, metabolomics profiling of esophageal tumors, and more.